Incidence of Hypertriglyceridemia in Critically Ill Neonates Receiving Lipid Injectable Emulsions in Glass Versus Plastic Containers: A Retrospective Analysis

Journal of Pediatrics

Volumn 152, Issue 2, 2008, Pages

  Martin, Camilia R ^a,b   Dumas, Gregory J ^c   Shoaie, Claire ^a   Zheng, Zheng ^a   MacKinnon, Brenda ^a   Al Aweel, Issa ^a   Bistrian, Bruce R ^a,b   Pursley, DeWayne M ^a,b   Driscoll, David F ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLASS; LIPID; PLASTIC;

ARTICLE; BIRTH WEIGHT; CONTAINER; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PLASMA CLEARANCE; PRIORITY JOURNAL;

EID: 38149097548     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.06.038     Document Type: Article

References (26)

1. Chapter <729>. Globule size distribution in lipid injectable emulsions. Pharm Forum 30 (2004) 2235-2240
2. Driscoll D.F., Etzler F., Barber T.A., Nehne J., Niemann W., and Bistrian B.R. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int J Pharm 219 (2001) 21-37
3. Brans Y.W., Andrew D.S., Carrillo D.W., Dutton E.B., Menchaca E.M., and Puelo-Scheppke B.A. Tolerance of fat emulsions in very low birthweight neonates: effect of birthweight on plasma lipid concentrations. Am J Perinatol 7 (1990) 114-117
4. Park W., Paust H., Brosicke H., Knoblach G., and Helge H. Impaired fat utilization in parenterally fed low-birth-weight infants suffering from sepsis. JPEN 10 (1986) 627-630
5. Levene M.I., Wigglesworth J.S., and Desai R. Pulmonary fat accumulation after lipid infusion in the preterm infant. Lancet 2 (1980) 815-818
6. Periera G.R., Fox W.W., Stanley C.A., Baker L., and Schwartz J.G. Decreased oxygenation and hyperlipemia during intravenous fat infusions in premature infants. Pediatrics 66 (1980) 26-30
7. Prasertsom W., Phillipos E.Z., Van Aerde J.E., and Robertson M. Pulmonary vascular resistance during lipid infusion in neonates. Arch Dis Child Fetal Neonatal Ed 74 (1996) F95-F98
8. Sirota L., Straussberg R., Notti I., and Bessler H. Effect of lipid emulsion on IL-2 production by mononuclear cells of newborn infants and adults. Acta Paediatr 86 (1997) 410-413
9. Stahl G.E., Spear M.L., and Hamosh M. Intravenous administration of lipid emulsions to premature infants. Clin Perinatol 13 (1986) 133-162
10. Putet G. Lipid metabolism of the micropremie. Clin Perinatol 27 (2000) 57-69
11. Liposyn III 20% product package insert (2000), Abbott Laboratories, North Chicago, IL revised May
12. Intralipid 20% product package insert (2000), Baxter Healthcare Corporation and Fresenius Kabi, Deerfield, IL and Uppsala, Sweden revised April
13. Announcement to Directors of Pharmacy: Intralipid IV fat emulsion now available in plastic containers (2004), Baxter Healthcare Corp February 26
14. Driscoll D.F., and Bistrian B.R. The effects of packaging containers on the large-diameter tail of the globule size distribution (GSD) of lipid emulsions. Clin Nutr 24 (2005) 699
15. Fenton T.R. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 3 (2003) 13
16. Toce S.S., and Keenan W.J. Lipid intolerance is associated with hepatic dysfunction but not infection. Arch Pediatr Adolesc Med 149 (1995) 1249-1253
17. American Academy of Pediatrics, and Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics 75 (1985) 976-986
18. Denne S.C., Clark S.E., Poindexter B.B., Leitch C.A., Ernst J.A., Lemons P.K., et al. Nutrition and metabolism in the high-risk neonate. In: Fanaroff A.A., and Martin R.J. (Eds). Neonatal-Perinatal Medicine. 6th edition (1997), Mosby, St Louis, MO 596
19. Rudolph C.D. Gastroenterology and nutrition. In: Rudolph C.D., and Rudolph A.M. (Eds). Rudolph's Pediatrics (2003), McGraw-Hill, New York 1344-1349
20. Allen K.G.D., and Harris M.A. The role of n-3 fatty acids and gestation and parturition. Exp Biol Med 226 (2001) 498-506
21. Driscoll D.F., Thoma A., Klütsch K., Bistrian B.R., and Nehne J. The effects of packaging containers and manufacturer on the large-diameter tail of the globule size distribution of lipid injectable emulsions, part 2. Clin Nutr 24 (2005) 1126-1127
22. Driscoll D.F., Silvestri A.P., Bistrian B.R., and Mikrut B.A. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging. Am J Health Syst Pharm 64 (2007) 396-403
23. Driscoll D.F., Ling P.R., and Bistrian B.R. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging. JPEN 31 (2007) 148-153
24. Qi K., Al-Haideri M., Seo T., Carpentier Y.A., and Deckelbaum R.J. Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions. JPEN 27 (2003) 58-64
25. Olivecrona G., and Olivecrona T. Clearance of artificial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1 (1998) 143-151
26. Fat tolerance from lipid emulsion infusion packaged in glass or plastic (study ID: 2005-P-00275; identifier: NCT00278928). Atlanta, GA: National Institutes of Health, 2006. http://www.clinicaltrials.gov/ct/show/NCT00278928?order=1 Accessed January 18, 2006